↓ Skip to main content

Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy

Overview of attention for article published in BMC Cancer, October 2012
Altmetric Badge

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
37 Mendeley